DESCRIPTION OF AMENDMENT. MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.) The purpose of this modification is to increase funding to the contract, add additional work, and extend the period of performance 9 months. This modification is also authorization the purchase the following equipment: A. Amersham FineLine 75 Column including a Source 15Q anion-exchanger packing: Estimated at $10,000. B. Millipore Ultra filtration Equipment: Estimated at $10,000. ▇. ▇▇▇▇▇ Mini Spray Dryer B-290 Advanced: Estimated at $22,000. See Summary of Changes for details. Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect. 15A. NAME AND TITLE OF SIGNER (Type or print) 16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print) TEL: EMAIL: 15B. CONTRACTOR/OFFEROR 15C. DATE SIGNED 16B. UNITED STATES OF AMERICA 16C. DATE SIGNED BY (Signature of person authorized to sign) (Signature of Contracting Officer) EXCEPTION TO SF 30 APPROVED BY OIRM 11-84 30-105-04 STANDARD FORM 30 (Rev. 10-83) Prescribed by GSA FAR (48 CFR) 53.243 SECTION SF 30 BLOCK 14 CONTINUATION PAGE SECTION A - SOLICITATION/CONTRACT FORM The total cost of this contract was increased by $6,000,000.00 from $6,000,001.00 to $12,000,001.00. SECTION B - SUPPLIES OR SERVICES AND PRICES CLIN 0001 The estimated/max cost has increased by $6,000,000.00 from $6,000,001.00 to $12,000,001.00. The total cost of this line item has increased by $6,000,000.00 from $6,000,001.00 to $12,000,001.00. SUBCLIN 000102 is added as follows: 000102 COST Add-On Proposal entitled: “Prevention of Anthrax Infection by CpG Oligodeoxynucleotices” is hereby incorporated and made a part of this contract. ESTIMATED COST $ 6,000,000.00 ACRN AB Funded Amount $ 5,998,693.00 ACRN AC Funded Amount $ 1,307.00 SECTION F - DELIVERIES OR PERFORMANCE The period of performance in Section F.1 of this contract is amended to reflect an increase of an additional nine months of performance. Amend Section F1, Period of Performance: FORM: 6 December 2003 – 5 June 2003 TO: 6 December 2003 – 4 March 2004 SECTION G - CONTRACT ADMINISTRATION DATA Accounting and Appropriation Summary for the Payment Office As a result of this modification, the total funded amount for this document was increased by $6,000,000.00 from $6,000,001.00 to $12,000,001.00. SUBCLIN 000102: Funding on SUBCLIN 000102 is initiated as follows: ACRN: AB Acctng Data: 970304040013010181293RPAROD3310M9270PU255Y3AR44498LSVC013XVC01018129 Increase: $5,998,693.00 Total: $5,998,693.00 ACRN: AC Acctng Data: 970203040013010181292RPAROD2310P1480PU255Y2AR44498LSTE012XTE01018129 Increase: $1,307.00 Total: $1,307.00 (End of Summary of Changes) AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT 1. CONTRACT ID CODE PAGE OF PAGES
Appears in 2 contracts
Sources: Contract (Coley Pharmaceutical Group, Inc.), Contract (Coley Pharmaceutical Group, Inc.)